Cue Biopharma Inc (CUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2006 | 12-2005 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 6,405 | N/A | N/A |
| Marketable Securities | 50 | N/A | N/A |
| TOTAL | $6,507 | $N/A | $N/A |
| Non-Current Assets | |||
| PPE Net | 710 | N/A | N/A |
| Other Non-Current Assets | 99 | 0 | 0 |
| TOTAL | $808 | $N/A | $N/A |
| Total Assets | $7,315 | $N/A | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 178 | 0 | 0 |
| Accrued Expenses | 119 | N/A | N/A |
| TOTAL | $342 | $N/A | $N/A |
| Non-Current Liabilities | |||
| Deferred Revenues | 46 | N/A | N/A |
| TOTAL | $34 | $N/A | $N/A |
| Total Liabilities | $376 | $N/A | $N/A |
| Shareholders' Equity | |||
| Common Shares | 7 | N/A | N/A |
| Retained earnings | -1,929 | N/A | N/A |
| TOTAL | $6,938 | $N/A | $N/A |
| Total Liabilities And Equity | $7,315 | $0 | $0 |